Skip to main content
OpenTrials
Completed

NCT Number: NCT03100461

Adaptive Intervention to Maximize Colorectal Screening in Safety Net Populations

The goal of this study is to find the best ways to increase colorectal cancer (CRC) screening.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Colorectal Cancer Colonic Diseases Colonic Neoplasms Colorectal Neoplasms Digestive System Diseases Digestive System Neoplasms Gastrointestinal Diseases Gastrointestinal Neoplasms Intestinal Diseases Intestinal Neoplasms Neoplasms Neoplasms by Site Rectal Diseases

Age range

50 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Kansas Medical Center

Kansas City, Kansas, 66160, United States

About this study

Colorectal Cancer is preventable and curable but is still the second most common cause of cancer death in the U.S. Minorities and those with low income have more CRC than middle and high income Whites.. They also get fewer CRC screening tests. Low knowledge of CRC screening may, in part, drive this lower test use. We need new ways to improve CRC screening in primary care clinics where many minority and uninsured patients receive health care.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Have a home address and access to a working telephone
  • Pass Mini-Cog assessment

Exclusion criteria

  • FIT (fecal immunochemical test) test within 1 year, Sigmoidoscopy or Barium enema within 5 years, or Colonoscopy within 10 years
  • Acute medical illness,
  • current GI bleed
  • history of adenomatous polyps
  • Colorectal Cancer
  • 1st degree relative with CRC < age 60 years
  • inherited polyposis/non-polyposis syndrome
  • inflammatory bowel disease
  • Another household member enrolled in the study

Treatment and study plan

I2

Other

A touch screen computer delivered "implementation intentions" (I2) intervention on CRC screening. "Implementation intentions" are the exact steps (the when, what, where, how) one will take to complete a test (the date and time, at home or at the doctor's office, with what supplies, etc.).

Other names: Implementation Intentions

Health education

Other

Standard of care approach that will provide basic information on CRC screening.

Primary outcomes

  1. CRC screening completion rate

    Time frame: 12-14 Months

    Rate of participants who receive CRC screening during study participation

Secondary outcomes

  1. Cost analysis of each intervention pathway

    Time frame: 14 Months

    Measure will be calculated by estimating all cost factors in the CRC screening process, include personnel and materials/supplies costs, materials development costs, and time of all study staff involved. Measure represented as a per participant cost to complete screening.

Sponsors and collaborators

Lead sponsor

University of Kansas Medical Center

Other

Collaborators

  • National Cancer Institute (NCI)

Registry information

Acronym: AIMSS

Important dates

Study start
2018
Primary completion
2022
Study completion
2022
First posted
Apr 4, 2017
Registry last updated
Oct 15, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.